These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 30098721

  • 1. Gastric Carcinoids.
    Grozinsky-Glasberg S, Alexandraki KI, Angelousi A, Chatzellis E, Sougioultzis S, Kaltsas G.
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):645-660. PubMed ID: 30098721
    [Abstract] [Full Text] [Related]

  • 2. Management of gastric carcinoids (neuroendocrine neoplasms).
    Kidd M, Gustafsson BI.
    Curr Gastroenterol Rep; 2012 Dec; 14(6):467-72. PubMed ID: 22976575
    [Abstract] [Full Text] [Related]

  • 3. Gut neuroendocrine tumors.
    Warner RR.
    Curr Ther Endocrinol Metab; 1997 Dec; 6():606-14. PubMed ID: 9174816
    [No Abstract] [Full Text] [Related]

  • 4. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
    Zhang P, Zhang Y, Zhang C, Shi Y, Liu J, Liu Q, Yu L, Wang M, Zou G, Lou J, Chen J, Tan H.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov 25; 19(11):1241-1246. PubMed ID: 27928793
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?
    Scherübl H, Cadiot G, Jensen RT, Rösch T, Stölzel U, Klöppel G.
    Endoscopy; 2010 Aug 25; 42(8):664-71. PubMed ID: 20669078
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T, Keller G, Bordi C, Höfler H.
    Lab Invest; 1999 Jun 25; 79(6):671-7. PubMed ID: 10378509
    [Abstract] [Full Text] [Related]

  • 9. Response and relapse rates after treatment with long-acting somatostatin analogs in multifocal or recurrent type-1 gastric carcinoids: A systematic review and meta-analysis.
    Rossi RE, Invernizzi P, Mazzaferro V, Massironi S.
    United European Gastroenterol J; 2020 Mar 25; 8(2):140-147. PubMed ID: 32213066
    [Abstract] [Full Text] [Related]

  • 10. A clinical perspective on gastric neuroendocrine neoplasia.
    Lawrence B, Kidd M, Svejda B, Modlin I.
    Curr Gastroenterol Rep; 2011 Feb 25; 13(1):101-9. PubMed ID: 21080245
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neuroendocrine tumors of the gastrointestinal tract.
    Chejfec G, Falkmer S, Askensten U, Grimelius L, Gould VE.
    Pathol Res Pract; 1988 Apr 25; 183(2):143-54. PubMed ID: 3290866
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gastric and duodenal neuroendocrine tumours.
    O'Toole D, Delle Fave G, Jensen RT.
    Best Pract Res Clin Gastroenterol; 2012 Dec 25; 26(6):719-35. PubMed ID: 23582915
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids.
    Jianu CS, Fossmark R, Syversen U, Hauso Ø, Fykse V, Waldum HL.
    Scand J Gastroenterol; 2011 Apr 25; 46(4):456-63. PubMed ID: 21133821
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow up of patients with multiple gastric carcinoids associated with type A gastritis.
    Hosokawa O, Kaizaki Y, Hattori M, Douden K, Hayashi H, Morishita M, Ohta K.
    Gastric Cancer; 2005 Apr 25; 8(1):42-6. PubMed ID: 15747174
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.